Skip to content

Saline Assisted Local Anesthetic Technique (SALT)

Effect of Intra-osseous Saline Injection in Pain Management during Surgical Removal of Mandibular Impacted 3rd Molars - A Randomised Double- Blinded Study - SALT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034039
Enrollment
160
Registered
2021-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: O- Medical and Surgical Health Condition 3: R52- Pain, unspecified

Interventions

Intervention1: Administering Intra-osseous Injections: We will intervene the patients who has intra-operative pain during mandibular 3rd molar surgeries by administering intraosseous injections. Contr

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The inclusion criteria were as follows: 1.Patients above 19 years of age, requiring surgical removal of impacted mandibular third molar. 2.Patients with pain while osteotomy at cancellous level during the procedure. 3.Patients with pain while splitting the tooth (odontectomy) or while luxating the tooth. 4.Patients who understood and were willing to follow all study protocols and who gave written consent.

Exclusion criteria

Exclusion criteria: 1.Patients below 19 years of age 2.Patients with severe infection 3.Patients with no pain while osteotomy of the bone at cancellous level or while splitting and luxating the tooth. 4.Patients with known allergies to local anesthetics (amides and esters) 5.Patients with other systemic diseases 6.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
To assess the pain using VAPS (Visual Analog Pain Scale) intra-operatively at baseline, after administering Intra-osseous injections, 4week and 8 week after the procedure.Timepoint: To assess the pain using VAPS (Visual Analog Pain Scale) intra-operatively at baseline and after administering Intra-osseous injections, 4week and 8 week after the procedure.

Secondary

MeasureTime frame
Clinical complications will assessed at baseline and after 1 week.Timepoint: Clinical complications will assessed at baseline and after 1 week.

Countries

India

Contacts

Public ContactJawahar Babu S

Sri Ramachandra Insititute of Higher Education and Research

naveenkumarj@sriramachandra.edu.in09884140960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026